Diagnostic and Interventional Cardiology DAIC

Diagnostic and Interventional Cardiology (DAIC) is a magazine that reaches more than 25,000 healthcare professionals in cardiology, interventional cardiology and cath labs across the United States. These influential buying team members rely on DAIC's award-winning editorial content and comparison charts as a unique research tool for specifying, recommending and approving technology/device purchases.

Immune response and the lymphatic system are central to cardiac repair after a heart attack, according to a study from Ann & Robert H. Lurie Children’s Hospital of Chicago and Northwestern University Feinberg Cardiovascular Research Institute.

News | Heart Failure

New Research Reveals How the Heart Repairs After a Heart Attack

May 25, 2022 — Immune response and the lymphatic system are central to cardiac repair after a heart attack, according to ...

May 25, 2022

A section of a normal healthy heart (left) and three locations in a heart from a patient with arrhythmogenic cardiomyopathy. There are a lot more fat cells (large while spheres) in the diseased heart. Cardiomyocytes in the composite region often show signs of degeneration, as well as enhanced ZBTB11 expression

News | Cardiovascular Clinical Studies

New Gene Identified in Arrhythmogenic Cardiomyopathy

May 25, 2022 — Researchers from the group of Eva van Rooij used advanced sequencing technology to better understand the ...

May 25, 2022

The ŌNŌ is intended to simplify bailout procedures in the expanding world of structural heart disease interventions

News | Structural Heart

ŌNŌCOR Receives FDA Clearance for Novel Endovascular Retrieval Technology

May 25, 2022 — ŌNŌCOR LLC, a leader in endovascular safety technology, today announced it has received 510(k) U.S. Food ...

May 25, 2022

News | Cardiovascular Business

Thomas E. MacGillivray Named Chair of Cardiac Surgery for MedStar Heart & Vascular Institute

May 25, 2022 — MedStar Heart & Vascular Institute announced that Thomas E. MacGillivray, MD, has been named physician ...

May 25, 2022

Amarin Corporation plc announced that research on the potential population health impact and cost-effectiveness of VASCEPA (icosapent ethyl), presented in two poster presentations at the American Heart Association’s Quality of Care and Outcomes Research Scientific Sessions in Reston, VA, May 13-14, 2022

News | Pharmaceuticals

Research Presented at AHA's QCOR Scientific Sessions Indicate Potential for Vascepa to Reduce Major Adverse CV Events

May 24, 2022 — Amarin Corporation plc announced that research on the potential population health impact and cost ...

May 24, 2022

The U.S. Food and Drug Administration (FDA) has issued a statement that Teva Pharmaceuticals USA has initiated a voluntary nationwide recall of a single lot of Anagrelide Capsules, USP 0.5 mg (Lot number GD01090), to the consumer level in the United States.

News | Pharmaceuticals

Teva Issues Voluntary Nationwide Recall of One Lot of Anagrelide Capsules

May 24, 2022 — The U.S. Food and Drug Administration (FDA) has issued a statement that Teva Pharmaceuticals USA has ...

May 24, 2022

A specific protein in blood vessel cells plays a major role in the development of vascular and cardiovascular diseases: The presence of too many "thromboxane A2 receptors" hinders the formation of new blood vessels.

News | Cardiovascular Clinical Studies

Researchers Find New Approach to Treating Cardiovascular Diseases

May 23, 2022 — A specific protein in blood vessel cells plays a major role in the development of vascular and ...

May 23, 2022

Percutaneous coronary interventions remain below pre-pandemic levels

News | STEMI

Nationwide Study Finds Significant Decline in Treatment for Heart Attacks During Pandemic

May 23, 2022 — New findings from the Ascension Health System’s internal National Cardiovascular Data Registry (NCDR) ...

May 23, 2022

Nationwide study points to implicit bias in treatment of cardiovascular disease for non-Hispanic Black patients and highlights need for equity

News | Heart Failure

Racial Disparities Seen in Treatment for Patients with Acute Coronary Syndrome and History of Cocaine Use

May 23, 2022 — Insights from a National Inpatient Sample Database examining race and the rates of cardiac ...

May 23, 2022

Findings underscore need to examine social factors that impact healthcare outcomes for most vulnerable

News | STEMI

New Study Finds Low-income Patients at Higher Risk of Death After Heart Attack

May 20, 2022 — Results from a retrospective analysis reveal significantly higher mortality rates for low-income ...

May 20, 2022

$Multi-center study explores new treatment for heart failure patients with preserved and reduced ejection fraction$

News | Heart Failure

No-implant Interatrial Shunt Device to Treat Heart Failure Patients Reveals Promising Multi-center Clinical Data

May 20, 2022 — Results from early clinical evaluation of the Alleviant System to treat heart failure patients with ...

May 20, 2022

News | Structural Heart

New Late-Breaking Data Highlight Abbott Structural Heart Transcatheter Valve Therapies

May 20, 2022 — Abbott announced two late-breaking data presentations highlighting both TriClip, a first-of-its kind ...

May 20, 2022

The Medtronic Harmony transcatheter pulmonary valve (TPV) system offers a less invasive treatment option for patients with a congenital heart defect irregularity in their right ventricular outflow tract (RVOT) that requires a pulmonary valve placement to restore valve function.

News | Heart Valve Technology

First Intermediate to Long-term Study of the Harmony Transcatheter Pulmonary Valve System Validates Safety and Efficacy

May 19, 2022 — A study of 1-year outcomes in the largest cohort to date of Harmony transcatheter pulmonary valve (TPV) ...

May 19, 2022

First multi-center, randomized controlled study provides the largest long-term evidence for the treatment of heavily calcified femoropopliteal lesions

News | Peripheral Artery Disease (PAD)

Disrupt PAD III Trial Demonstrates Safety and Effectiveness of Intravascular Lithotripsy for Peripheral Artery Calcification

May 19, 2022 — One year outcomes from the Disrupt PAD III Trial comparing intravascular lithotripsy (IVL) with a drug ...

May 19, 2022

The latest analysis from The North American COVID-19 STEMI (NACMI) was presented today as late-breaking clinical research at the Society for Cardiovascular Angiography & Interventions (SCAI) 2022 Scientific Sessions.

News | STEMI

International COVID-19 Registry Finds Significant Increased Risk of In-hospital Mortality for STEMI Patients with COVID-19 Compared to Pre-pandemic

May 19, 2022 — The latest analysis from The North American COVID-19 STEMI (NACMI) was presented today as late-breaking ...

May 19, 2022